摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

phomolide G | 1340493-47-1

中文名称
——
中文别名
——
英文名称
phomolide G
英文别名
(2R,4S,5S,6E,8S)-4,5,8-trihydroxy-2-propyl-2,3,4,5,8,9-hexahydrooxecin-10-one
phomolide G化学式
CAS
1340493-47-1
化学式
C12H20O5
mdl
——
分子量
244.288
InChiKey
PTCQELNOCBFIRX-VAVWPVAVSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0
  • 重原子数:
    17
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.75
  • 拓扑面积:
    87
  • 氢给体数:
    3
  • 氢受体数:
    5

反应信息

点击查看最新优质反应信息

文献信息

  • Enantioselective Total Synthesis of the Proposed Structure of the Endophytic Fungal Metabolite Phomolide G: Structural Revision and Unambiguous Stereochemical Assignment
    作者:James McNulty、David McLeod、Hilary A. Jenkins
    DOI:10.1002/ejoc.201501592
    日期:2016.2
    A total synthesis of the proposed structure of the natural macrolactone phomolide G (1) by a bidirectional strategy from L-tartaric acid is reported. The ω-terminus of the molecule was elaborated by nitrile extension, C3-alkylation and a substrate-controlled 1,3-ketone reduction. The α-terminus was extended by a C2 aldehyde-to-alkenal homologation followed by an auxiliary controlled aldol reaction
    报告了通过来自 L-酒石酸的双向策略对天然大环内酯 phomolide G (1) 的拟议结构进行全合成。分子的 ω 末端通过腈延伸、C3-烷基化和底物控制的 1,3-酮还原来精心设计。α-末端通过 C2 醛到链烯醛的同源性延伸,然后是辅助控制的醛醇反应。大环内酯化和脱保护产生化合物 1(通过 X 射线分析证实)。与天然产物相比,phomolide G 的这种假定结构显示出不一致的 NMR 光谱数据。对所有可用 NMR 光谱数据的详细检查表明,phomolide G 可能是 1 的非对映异构体。开发的合成策略允许控制所有四个手性仲醇基团的绝对立体化学。
  • Total Enantioselective Synthesis of the Endophytic Fungal Polyketide Phomolide H and Its Structural Revision
    作者:James McNulty、David McLeod
    DOI:10.1002/ejoc.201601172
    日期:2017.1.3
    A total synthesis of the proposed structure of the natural polyketide-macrolactone phomolide H 2 has been achieved following a bidirectional strategy from l-tartaric acid. The originally assigned structure of phomolide H displayed discordant NMR spectroscopic data in comparison with synthetic 2. The synthetic strategy was extended to prepare diastereomers and epimeric methyl-ethers of the natural product
    遵循 L-酒石酸的双向策略,已实现天然聚酮化合物-大环内酯 phomolide H 2 的拟议结构的全合成。与合成 2 相比,最初指定的 phomolide H 的结构显示出不一致的 NMR 光谱数据。 合成策略扩展到制备天然产物的非对映异构体和差向异构甲基醚,其结构分析显示天然产物与非对映异构体 27 匹配. 介绍了 pomolide H 从 2 到化合物 27 的甲醇溶剂化物的结构修正。
  • First stereoselective total synthesis of Phomolide G and H via RCM protocol
    作者:Palakuri Ramesh、B. Chennakesava Reddy、H.M. Meshram
    DOI:10.1016/j.tetlet.2012.04.118
    日期:2012.7
    A first total synthetic route has been reported for the synthesis of Phomolide G and H. The syntheses of fragments were initiated from commercially available and inexpensive starting material (R)-epichlorohydrin. The synthesis involves a key Sharpless epoxidation, stereoselective epoxide opening, lactonization and ring closing metathesis (RCM).
    已经报道了第一合成路线,用于合成草甘膦G和H。片段的合成是从可商购的且廉价的起始原料(R)-表氯醇开始的。合成涉及关键的Sharpless环氧化,立体选择性环氧化物开环,内酯化和闭环复分解(RCM)。
  • A Convergent and Stereoselective Total Synthesis of Phomolides G and H
    作者:B. Subba Reddy、P. Sivaramakrishna Reddy、B. Phaneendra Reddy、J. Yadav
    DOI:10.1055/s-0033-1340348
    日期:——
    A stereoselective total synthesis of phomolides G and H, a polyketide natural products is described. The synthesis involves organocatalytic enantioselective asymmetric epoxidation, C1-Wittig olefination, and ring-closing metathesis as key steps. The use of organocatalytic MacMillan asymmetric epoxidation for the construction of two chiral centers of phomolides G and H makes this approach more attractive
    描述了 phomolides G 和 H(一种聚酮化合物天然产物)的立体选择性全合成。该合成涉及有机催化对映选择性不对称环氧化、C1-Wittig 烯化和闭环复分解作为关键步骤。使用有机催化 MacMillan 不对称环氧化来构建两个心内酯 G 和 H 的手性中心使这种方法更具吸引力。
查看更多

同类化合物

胰岛素原(cattle),29-[N6-[[2-(甲磺酰)乙氧基]羰基]-L-赖氨酸]-59-[N6-[[2-(甲磺酰)乙氧基]羰基]-L-赖氨酸]-(9CI) 十氢-2,7-苯并二氧杂环癸烷-3,6-二酮 二环<3.3.0>-2-氧杂-5-(2-丙烯基)-1-辛烯 乙烯邻苯二甲酸酯 [(E,1R)-1-[(2R,4Z,7S,8R)-7-溴-8-乙基-3,6,7,8-四氢-2H-氧杂环辛三烯-2-基]己-3-烯-5-炔基]乙酸酯 [(2R,3S,4E,6R,7S)-6,7-二羟基-2-甲基-10-氧代-2,3,6,7,8,9-六氢氧杂环辛三烯-3-基] (E)-丁-2-烯酸酯 6,7-二氢-5aH-氧杂环丁烷并[3,2-d][1,3]苯并二氧戊环 5-氧杂-10-氮杂三环[5.3.1.03,8]十一碳-1(10),2,6,8-四烯 3-氧杂二环[3.3.1]壬-6-烯-9-酮 3,4,5,6-四氢-2,7-苯并二氧杂环癸烷e-1,8-二酮 10-(乙酰氧基)-4,5,6,7-四氢-2H-1-苯并氧杂环辛三烯-2,8(3H)-二酮 1-(2,3,4,5-四氢-1,6-苯并二噁辛英-8-基)丙烷-1-酮 1,2-环己烷二甲酸1-甲基-1,2-乙二基酯 (S)-5-烯丙基-2-氧杂双环[3.3.0]辛-8-烯 (7Z)-2-(3-溴丙-1,2-二烯基)-5-(1-溴丙基)-3,3a,5,6,9,9a-六氢-2H-呋喃并[3,2-b]氧杂环辛三烯 (7E)-4,7-二羟基-10-甲基-3,4,5,6,9,10-六氢氧杂环辛三烯-2-酮 (6Z)-10-甲基-3,4,5,8,9,10-六氢-2H-氧杂环辛三烯-2-酮 (5Z,8S)-3-氯-2-[(E)-戊-2-烯-4-炔基]-8-[(E)-丙-1-烯基]-3,4,7,8-四氢-2H-氧杂环辛三烯 (4Z)-3,6-二氢-2,7-苯并二氧杂环癸烷e-1,8-二酮 (4S,5Z,7S,8S,10R)-4,7,8-三羟基-10-甲基-3,4,7,8,9,10-六氢氧杂环辛三烯-2-酮 (4R,5R,6Z,8S,10R)-4,5,8-三羟基-10-甲基-3,4,5,8,9,10-六氢氧杂环辛三烯-2-酮 (2R,5Z)-8a-[(R)-1-溴丙基]-3a-氯-3,4,7,8-四氢-2a-[(Z)-2-戊烯-4-炔基]-2H-氧杂环辛三烯 1,3,3a,6a-tetrahydro-5-pentyl-4H-cyclopentafuran-4-one trans-1-oxacyclodec-7-ene-2-one 2-epi-herbarumin II (RS)-5-methoxy-2,3,5,6-tetrahydro-8H-benzo[1,4,7]trioxecin β-heptenolactone stagonolide-E fumaric acid butanediyl ester aspinolide A (3R,4R,9S,10R,Z)-4,9-dihydroxy-3-methyl-10-pentyl-3,4,7,8,9,10-hexahydro-2H-oxecin-2-one prelaureatin 8-acetyl-4,4-dimethyl-2,6-dioxo-9-(2-methylpropyl)-2,3,4,5,6,8-hexahydrooxocino[2,3-c]pyrrole 5,6-benzo-2,3-diethoxy-4-oxo-2-hepten-7-olide 3,4,5,6-tetrahydro-oxocin-2-one (Z)-3-butyl-5,6,7,8-tetrahydro-2H-oxocin-2-one presaccharothriolide X 1-{2-[4,5-dihydro-1H-2-benzoxocin-(6Z)-ylidenemethyl]-allyl}-piperidine (R,Z)-8-(methoxymethoxy)-2,2,6,9-tetramethyl-5,6-dihydro-2H-benzo[b]oxocine 5-hydroxy-7R,11-heliannan-10-one 8-methoxy-2,2,6,9-tetramethyl-2H-1-benzoxocin-3(4H)-one 8-methoxy-2,2,6,9-tetramethyl-3,4,5,6-tetrahydro-2H-1-benzoxocin-3-ol (4S,5Z,10R)-4-hydroxy-10-methyl-3,4,7,8,9,10-hexahydro-2H-oxecin-2-one (4R)-9,11-bis(benzyloxy)-4-methyl-4,5,6,7-tetrahydro-1H-benzo[d]-oxecine-2,8-dione ethyl (4Z)-4-methyl-7,8-dihydro-1,3,6-trioxocine-5-carboxylate 4-hydroxy-10-(2-hydroxyethyl)-1,2-dihydro-4,12a-methanooxocino[4,5-b][1,4]benzodioxin-5-one 4-hydroxy-9-(2-hydroxyethyl)-1,2-dihydro-4,12a-methanooxocino[4,5-b][1,4]benzodioxin-5-one (7R,9R,5E)-7-hydroxy-9-propylnon-5-en-9-olide (6S,7R,9R)-6,7-dihydroxy-9-propylnon-4-eno-9-lactone 7-[2-(3,5-Dichloro-N-oxo-pyridin-4-yl)-1-oxoethyl]-10-methoxy-2,3,4,5-tetrahydro-1,6-benzodioxocine